Embecta (EMBC) Net Income towards Common Stockholders (2020 - 2026)

Embecta's (EMBC) quarterly Net Income towards Common Stockholders came in at -$4.1 million in Q1 2026, down 117.45% year-on-year from $23.5 million in Q1 2025, and down 109.3% quarter-over-quarter from $44.1 million in Q4 2025.

Embecta (EMBC) Net Income towards Common Stockholders (2020 - 2026) Analysis & Trends

Embecta has disclosed Net Income towards Common Stockholders across 7 years of filings, most recently posting -$4.1 million for Q1 2026.

  • Net Income towards Common Stockholders for Q1 2026 came in at -$4.1 million, down 117.45% year-over-year; the trailing twelve-month figure through Mar 2026 was $111.9 million (up 111.93% YoY), and the FY2025 annual result was $95.4 million, up 21.84% from the prior year.
  • Net Income towards Common Stockholders came in at -$4.1 million for Q1 2026 at Embecta, down from $44.1 million in the prior quarter.
  • In the past five years, Net Income towards Common Stockholders ranged from a high of $79.6 million in Q1 2022 to a low of -$17.2 million in Q3 2022.
  • The 5-year median for Net Income towards Common Stockholders is $21.8 million (2023), against an average of $25.6 million.
  • Across the five-year window, Net Income towards Common Stockholders plunged 117.75% in 2022 and soared 209.52% in 2025, its largest moves.
  • Embecta's Net Income towards Common Stockholders stood at $35.2 million in 2022, then sank by 42.9% to $20.1 million in 2023, then decreased by 27.36% to $14.6 million in 2024, then soared by 202.05% to $44.1 million in 2025, then plunged by 109.3% to -$4.1 million in 2026.
  • The last three Net Income towards Common Stockholders figures came in at -$4.1 million (Q1 2026), $44.1 million (Q4 2025), and $26.4 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income (Qtr)
1 Intuitive Surgical 148.09 Bn 143.69 Bn 1.83 Bn 826.00 Mn
2 Becton Dickinson 41.00 Bn 39.99 Bn 2.15 Bn -274.00 Mn
3 Medline 30.38 Bn 36.22 Bn 1.84 Bn 239.00 Mn
4 Resmed 28.22 Bn 26.56 Bn 890.98 Mn 398.73 Mn
5 West Pharmaceutical Services 23.72 Bn 23.19 Bn 296.40 Mn 135.40 Mn
6 Solventum 13.33 Bn 13.33 Bn 1.10 Bn 13.00 Mn
7 Cooper Companies 13.12 Bn 12.99 Bn 735.40 Mn -77.90 Mn
8 Align Technology 12.86 Bn 11.80 Bn 736.59 Mn 112.77 Mn
9 Baxter International 10.51 Bn 8.47 Bn 891.00 Mn 2.00 Mn
10 Embecta 183.23 Mn -10.17 Mn 127.80 Mn -4.10 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -4.10 Mn
Dec 31, 2025 44.10 Mn
Sep 30, 2025 26.40 Mn
Jun 30, 2025 45.50 Mn
Mar 31, 2025 23.50 Mn
Sep 30, 2024 14.60 Mn
Jun 30, 2024 14.70 Mn
Mar 31, 2024 28.90 Mn
Dec 31, 2023 20.10 Mn
Sep 30, 2023 6.00 Mn
Jun 30, 2023 15.20 Mn
Mar 31, 2023 14.00 Mn
Dec 31, 2022 35.20 Mn
Sep 30, 2022 -17.20 Mn
Jun 30, 2022 62.40 Mn
Mar 31, 2022 79.60 Mn
Dec 31, 2021 98.80 Mn
Sep 30, 2021 96.90 Mn
Jun 30, 2021 104.70 Mn
Mar 31, 2021 107.90 Mn